عنوان

Trends in Inflammatory Bowel Disease Therapy 1999 :

(Number (ISBN

9401140022

(Number (ISBN

9789401140027

Number

b549996

Title Proper

Trends in Inflammatory Bowel Disease Therapy 1999 :

General Material Designation

[Book]

Other Title Information

the proceedings of a symposium organized by AXCAN PHARMA, held in Vancouver, BC, August 27-29, 1999

First Statement of Responsibility

edited by C.N. Williams, R.F. Bursey, D.G. Gall, F. Martin, R.S. McLeod, L.R. Sutherland, J.L. Wallace.

Place of Publication, Distribution, etc.

Dordrecht

Name of Publisher, Distributor, etc.

Springer Netherlands

Date of Publication, Distribution, etc.

2000

Specific Material Designation and Extent of Item

(xvi, 262 pages)

Text of Note

Section I: Genetics --;1 Genetics of Inflammatory bowel disease: where are we? --;2 Genetics of inflammatory bowel disease: why is it important? --;3 Genetics of IBD: impact on immune function --;Section II: Pathogenesis --;4 Bacterial factors in inflammatory bowel disease pathogenesis --;5 Inflammatory bowel disease: autoimmunity or chronic inflammation? --;6 Neutrophil --;epithelial interactions, and efforts to down-regulate them, in inflammatory bowel disease --;7 Understanding inflammatory bowel disease at the millennium: tentative answers and future questions --;Section III: Clinical Challenges in Inflammatory Bowel Disease --;8 Diagnosis of inflammatory bowel disease: an update --;9 Recent developments in the diagnosis and management of paediatric inflammatory bowel disease --;10 Inflammatory bowel disease in the elderly --;Section IV: Current Therapy in Inflammatory Bowel Disease --;11 Induction of remission in ulcerative colitis --;12 Remission maintenance in ulcerative colitis --;13 Induction therapy for Crohn's disease --;14 Maintenance of remission in Crohn's disease --;Section V: Bone Disease in Inflammatory Bowel Disease --;15 Risk factors and prevalence of bone disease in inflammatory bowel disease --;16 Management of low bone mass in patients with inflammatory bowel disease --;17 Steroid-induced osteonecrosis in inflammatory bowel disease: Canadian legal status --;Section VI: Alternative Therapy --;18 Psychotherapy for inflammatory bowel disease: new prospects --;19 The use of complementary and alternative medicine by patients with inflammatory bowel disease --;20 Gut inflammation: is there a role for herbal medicines? --;21 The role of nutrition in the treatment of inflammatory bowel disease --;Section VII: New Therapeutic Approaches --;22 Antibodies to proinflammatory cytokines --;23 Immunomodulation of Crohn's disease --;24 Application of recombinant DNA technology to the identification of novel therapeutic targets in inflammatory bowel disease --;25 The use of probiotics in inflammatory bowel disease.

Text of Note

This Trends in Inflammatory Bowel Disease Therapy Symposium was held in Vancouver, British Columbia, Canada, 27~29 August 1999. This is the seventh international symposium, sponsored by Axcan Pharma Canada Inc., since the first symposium in 1986.

Gastroenterology.

Medicine.

Class number

Book number

edited by C.N. Williams, R.F. Bursey, D.G. Gall, F. Martin, R.S. McLeod, L.R. Sutherland, J.L. Wallace.

C N Williams

Electronic name

[Book]

Y